NKP46 EXPRESSION IS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER IN PRIMARY GASTROINTESTINAL T‐CELL LYMPHOPROLIFERATIONS. A CELAC NETWORK STUDY
Morgane Cheminant(Hôpital Necker-Enfants Malades), Olivier Hermine(Centre National de la Recherche Scientifique), Amélie Trinquand(Hôpital Necker-Enfants Malades), Nicole Brousse(Hôpital Necker-Enfants Malades), Florence Lhospice(Innate Pharma (France)), Julie Bruneau(Délégation Paris 5), Felipe Suárez(Hôpital Necker-Enfants Malades), Christophe Cellier(Assistance Publique – Hôpitaux de Paris), Vahid Asnafi(Hôpital Necker-Enfants Malades), Richard Delarue(Hôpital Necker-Enfants Malades), Ludovic Lhermitte(Hôpital Necker-Enfants Malades), Elizabeth Macintyre(Inserm), Cécile Bonnafous(Innate Pharma (France)), Georgia Malamut(Délégation Paris 5), Thierry Jo Molina(Hôpital Necker-Enfants Malades), Ambroise Marçais(Hôpital Necker-Enfants Malades), Nicolas Guégan(Délégation Paris 5), David Sibon(Hôpital Necker-Enfants Malades), Bertrand Meresse(Centre Hospitalier Universitaire de Lille), Laurent Frenzel(Hôpital Necker-Enfants Malades), Nadine Cerf–Bensussan(Université Paris Cité)
Cited by 2
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k